Jonathan Walker and Civil Aviation Safety Authority

Link copied
Case Copied 29 min read

[2014] AATA 169  

Division GENERAL ADMINISTRATIVE DIVISION

File Number(s)

2013/0533

2013/1580

Re

Jonathan Walker

APPLICANT

And

Civil Aviation Safety Authority

RESPONDENT

DECISION

Tribunal

Deputy President PE Hack SC
Dr W Isles, Member

Date 28 March 2014
Place Brisbane

A. In application 2013/0533 the decision under review is set aside and a decision substituted that a class 2 medical certificate not be issued to the applicant.

B. In application 2013/1580 the decision under review is affirmed.

................[Sgd]........................................................

Deputy President PE Hack SC

CATCHWORDS

CIVIL AVIATION – medical certificate – juvenile myoclonic epilepsy – extent to which relevant medical standard not met – whether a deficiency likely to endanger the safety of air navigation.

LEGISLATION

Civil Aviation Act 1988 (Cth) ss 9A(1), 11, 20AB(1)

Civil Aviation Regulations 1988 (Cth) reg 5.04(1)

Civil Aviation Safety Regulations 1998 (Cth) regs 11.055, 67.180, 67.150, 67.15, 67.015

CASES

Re Walker & Civil Aviation Safety Authority [2009] AATA 674

Re Window & CASA [1999] AATA 525;  (1999) 56 ALD 316

Re Hall & CASA [2004] AATA 21

REASONS FOR DECISION

Deputy President PE Hack SC
Dr W Isles, Member

28 March 2014

Introduction

  1. The applicant, Mr Jonathan Walker, is a pilot.  He obtained a private pilot licence in October 2006 and a commercial pilot licence in January 2012.  He aspires to be a commercial pilot but suffers from a condition called juvenile myoclonic epilepsy. 

  2. The respondent, the Civil Aviation Safety Authority, has the statutory responsibility for issuing aviation medical certificates.  Even with an appropriate pilot licence a pilot may not exercise the privileges of a licence except with a medical certificate appropriate for that class of licence.

  3. In December 2012, when it came time for Mr Walker's medical certificate (as a private pilot) to be renewed, CASA imposed certain conditions on the certificate that Mr Walker found unacceptable.  Then, in April 2013, CASA refused to issue him with the medical certificate that he requires to exercise the privileges of the holder of a commercial pilot licence. Mr Walker seeks a review of each of these decisions.

  4. There is a further issue to be noted at this juncture.  CASA does not seek to have the Tribunal affirm its December 2012 decision.  The effect of its argument is that, in light of the evidence now available, its earlier decision was not warranted and that the correct or preferable decision that the Tribunal ought make in substitution for it is a decision revoking the medical certificate of December 2012. It says that Mr Walker’s condition is such that no certificate, even one with conditions, may be issued to him.

  5. Mr Walker puts in issue the entitlement of CASA’s right to seek to depart from its earlier decision.  Expressed somewhat broadly, he contends that the decision to issue the certificate is not the subject of his application; that application concerns only the imposition of conditions.  Implicit in Mr Walker's argument is the suggestion that, in truth, CASA is seeking to review an earlier decision of the Tribunal[1] which was favourable…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Jonathan Walker and Civil Aviation Safety Authority and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2014] AATA 169
Decision Date

CaseChat Overview and Summary

The case of Jonathan Walker against the Civil Aviation Safety Authority (CASA) involves a dispute over the revocation of Mr Walker's medical certificate by CASA, which prevented him from exercising his occupation as a commercial pilot. The central issue was whether Mr Walker's juvenile myoclonic epilepsy constituted a deficiency likely to endanger the safety of air navigation. The court was tasked with determining whether Mr Walker met the relevant medical standards and whether his condition posed a risk to air safety.

The court examined the extent to which Mr Walker did not meet the relevant medical standards for a Class 1 or Class 2 medical certificate. The evidence indicated that Mr Walker had a history and diagnosis of juvenile myoclonic epilepsy, which disqualified him from meeting the criteria in Item 1.7(b) of Table 67.150 of the Civil Aviation Safety Regulations. The court considered whether Mr Walker's condition was a deficiency likely to endanger the safety of air navigation, focusing on the likelihood of future seizures and their impact on his ability to safely operate an aircraft. The court weighed expert medical evidence, including opinions from several neurologists, to assess the risk posed by Mr Walker's epilepsy.

The court found that Mr Walker did not meet the relevant medical standards due to his established diagnosis of juvenile myoclonic epilepsy. The recent video EEG confirmed the persistence of this condition, which alone was disqualifying. The court also concluded that the risk of future seizures, even if managed with medication, posed a significant threat to air safety, thereby justifying the revocation of Mr Walker's medical certificate. The court's decision was based on the potential for sudden incapacitation due to seizures, which could endanger the safety of air navigation.

The court upheld CASA's decision to revoke Mr Walker's medical certificate, finding that his juvenile myoclonic epilepsy constituted a deficiency likely to endanger the safety of air navigation. The evidence indicated that Mr Walker's condition disqualified him from meeting the necessary medical standards and that the risk of future seizures justified the revocation of his certificate. The decision underscored the importance of stringent medical standards in aviation to ensure the highest level of safety for all passengers and crew.

Background

Background to the litigation

It takes little imagination to envisage the potential consequences to a pilot’s capacity to adequately control an aircraft if subject to any of these symptoms however there is a considerable body of evidence dealing with those possible consequences. We discuss that evidence below.Some uncontroversial background Mr Walker was born in 1982 and is now just short of his 32nd birthday. In 2002 he was involved in a motor cycle accident. A bike that he was riding collided head-on with another bike. Mr Walker was briefly concussed but not otherwise injured. There is some controversy about the circumstances of this accident and, in particular, whether it evidenced a seizure. We will return to this episode in due course. In 2004, when he was 22 years old, he was employed as a roadside mechanic, an occupation that required him to be on call for the whole of a weekend from 6 pm on Friday until 6 pm on Sunday. During 2004, and invariably after the consumption of alcohol and working excessive hours, Mr Walker first noticed jerks or spasms in his hands in the first hour or so after waking of a morning. In July 2004 Mr Walker was taken by ambulance to the Royal Brisbane Hospital following an incident in a nightclub. On admission he described a history of six months of episodes recorded as seizures or fits. This event is of considerable importance in the medical history and the development of juvenile myoclonic epilepsy in Mr Walker. Again, we will return to examine the evidence of this episode in greater detail. In August 2004[4] Mr Walker obtained a student pilot licence. He was issued with a Class 1 Medical Certificate in February 2005 and commenced training to obtain a commercial pilot licence shortly thereafter. His Class 1 Medical Certificate was renewed in February 2006. [4]The date is taken from Exhibit 12, the Applicant's Statement of Facts and Contentions. In the earlier decision, and the date of issue of the student pilot licence is recorded as 5 August 2005: see Re Walker & CASA [2009] AATA 674 at [14]. Nothing seems to turn on the discrepancy. In July 2006, at a time when Mr Walker had completed 76 flying hours (including 26 hours of solo flight), he consulted his Designated Aviation Medical Examiner (DAME), concerned that he was continuing to experience jerks on waking in the mornings. He was referred to Dr Limberg who diagnosed juvenile myoclonic epilepsy. He was referred for a second opinion to Dr John Cameron, another consultant neurologist who was, additionally, a DAME, and holds a Diploma in Aviation Medicine. Dr Cameron reached the same conclusion. Mr Walker was prescribed Epilim (sodium valproate), initially 400 mg per day. Epilim is an anti-convulsant. Mr Walker notified CASA of the fact of the diagnosis. In November 2011 CASA revoked Mr Walker's medical certificate. In the meantime in September 2006, Mr Walker had successfully completed the tests required to obtain a private pilot licence. In January 2008 Mr Walker ceased taking his medication. He wanted to demonstrate to CASA that he could be free of seizures without medication. In January 2009 CASA refused to issue Mr Walker with Class 1 and Class 2 medical certificates. Mr Walker sought a review of those decisions. In Re Walker & CASA[5] the Tribunal, differently constituted, set aside CASA’s decision and remitted the matter to CASA for reconsideration in accordance with a direction that a Class 2 medical certificate be issued to Mr Walker, but subject to conditions including a condition that he continue to take anti-epileptic medication as prescribed to him by a qualified medical practitioner in consultation with a qualified neurologist.[5][2009] AATA 674.

Decision

Reasons for decision

Issues
1. To what extent does Mr Walker not meet the relevant medical standard?
2. Is the deficiency which Mr Walker does not meet the relevant medical standard likely to endanger the safety of air navigation?

Held
1. The court concluded that Mr Walker does not meet the relevant medical standard to the extent that he has an established medical history and clinical diagnosis of juvenile myoclonic epilepsy.
2. The court concluded that the deficiency which Mr Walker does not meet the relevant medical standard is likely to endanger the safety of air navigation.

Ratio Decidendi

Legal Principle Established

In August 2013, under the supervision of Dr O'Brien, Mr Walker had inpatient EEG at the Royal Melbourne Hospital having ceased his medication three weeks earlier. That EEG was reported on in these terms,Abnormal interictal EEG due to frequent generalised epileptiform discharges.The EEG was consistent with primary generalised epilepsy disorder.Consideration There is no doubt that Mr Walker has both a history and a diagnosis of juvenile myoclonic epilepsy. The recent video EEG confirms that is still the case. The contrary was not suggested. That being so, it is axiomatic that he does not satisfy the criteria in Item 1.7(b) of Table 67.150 to the CASR nor the equivalent item in Table 67.155. He has an established medical history and clinical diagnosis of epilepsy. In those circumstances we do not regard it as necessary to consider whether he satisfies Items 1.1 or 1.8 of Table 67.150 or the equivalent items of Table 67.155. It is enough to say that Mr Walker does not meet the relevant medical standard for the issue of a class 1 medical certificate or a class 2 medical certificate. Thus the question that arises is whether Mr Walker meets the relevant requirements of reg 67.180(2)(e)(ii) of the CASR. That draws attention to two questions,(a)what is the extent to which Mr Walker does not meet the relevant medical standard; and,(b)is that a deficiency which is likely to endanger the safety of air navigation. We have a considerable body of medical evidence that touches on those issues. In some cases we have had the benefit of hearing (and seeing) medical witnesses giving evidence in addition to written reports, in other cases we have only written reports. We propose to start by making some general observations about the medical witnesses whose evidence we need consider. The critical issue in the proceedings, the likelihood of Mr Walker experiencing seizures in the future, has traditionally been regarded as coming within the expertise of neurologists. We have reports, and have heard evidence from, Associate Professor Ernest Somerville, Dr John D Hastings, Professor Samuel F Berkovic and Professor Terrence O’Brien. All are well-qualified neurologists. We found the views of Dr Somerville, Dr Berkovic and Dr O'Brien most helpful. We are not able to say the same about the evidence of Dr Hastings. He seemed more concerned to recount the position in the United States (where he resides and practices) rather than speak to matters of medical opinion. His views, from which he would not waver, were expressed in this way in this report of 9 June 2013,[7]From an aeromedical regulatory standpoint, a diagnosis of epilepsy has long been considered as a bar to all classes of medical certificate. In the United States, the Federal Aviation Act of 1958 included epilepsy among the original conditions requiring mandatory denial of medical certification. In 1979 an expert FAA panel led to a recommendation of permanent denial for all classes for a single seizure beyond age 5. In 1986 full remission for 20 years with a normal EEG and negative screen for anti-epileptic medication was recommended (unpublished data). In the early 1990s the "Rule of Tens" (ten years seizure-free, 10 years medication-free) came into practice. Current FAA policy for epilepsy (not otherwise specified) is ten years of seizure-freedom, three years medication-freedom.…From an aeromedical certification standpoint, the diagnosis [of juvenile myoclonic epilepsy] alone is disqualifying for all classes of FAA medical certification. I am in agreement with this determination.Despite this evidence Dr Hastings agreed that there was a discretion in the United States regulatory scheme to allow for the issue of a medical certificate to a person with epilepsy.[7] Exhibit 6, pages 4-5.